Dr. Dawson on Increasing Causes and Unmet Needs in HCC

Video

Laura Dawson, MD, Princess Margaret Hospital, University of Toronto, discusses increasing cause of hepatocellular carcinoma (HCC) and unmet needs related to the disease.

Laura Dawson, MD, Princess Margaret Hospital, University of Toronto, discusses increasing causes of hepatocellular carcinoma (HCC) and unmet needs related to the disease.

A growing cause of liver cancer is nonalcoholic steatohepatitis (NASH), which can lead to cirrhosis. Dawson says there is a time lapse from when patients with metabolic syndrome can possibly develop NASH, which may lead to cirrhosis. This cause is rapidly increasing, and Dawson says HCC mortality rates are likely to increase in the next few decades.

These predicted increases should lead researchers to make HCC a priority cancer for treatment, screening, and researching treatment outcomes, Dawson says. As more patients will be affected by this disease, she adds that more researchers should work on clinical trials to help move the treatment paradigm forward.

Related Videos
Rita Nanda, MD
Vikram Narayan, MD
Daniel Olson, MD
Vishal Patel, MD, FAAD, FACMS, associate professor, Dermatology, George Washington (GW) School of Medicine & Health Sciences
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine
Jorge J. Castillo, MD,
Heinz-Josef Lenz, MD, FACP
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Omid Hamid, MD, professor, medicine, Cedars-Sinai; director, Clinical Research and Immunotherapy, director, Cutaneous Oncology and Melanoma, The Angeles Clinic and Research Institute
Christina L. Roland, MD, MS, FACS